Kevin Lilly most recently served as the senior vice president of sales at MiMedx, a biopharmaceutical company focused on regenerative medicines. Working from the Atlanta suburb of Marietta, Georgia, Kevin Lilly oversaw a portfolio comprising biopharmaceuticals and HCT/Ps (human cells, tissues, and cellular and tissue-based products) marketed to medical professionals and facilities. Mr. Lilly worked with the company from 2015 to 2019, and in this time he doubled MiMedx’s sales figures, which reached $385 million in 2018.

Before joining MiMedx, Mr. Lilly enjoyed similar success at Standard Register Healthcare, where he served as the vice president of marketing and product management. At Standard Register, he led the development and commercialization efforts for a portfolio of new software solutions including Effective Response (post-encounter follow-up) and Care Communication (personal support network). Mr. Lilly also excelled in healthcare sales roles with McKesson, Spectrx, and other companies.

A recipient of an MBA in international management from Thunderbird, the American Graduate School of International Management (now known as the Thunderbird School of Global Management at Arizona State University), Mr. Lilly also holds dual bachelor’s degrees in management and marketing from Kansas State University.